The medical device plastics market is projected to grow from USD 21.93 billion in 2025 to USD 31.82 billion by 2030, at a CAGR of 7.7% during the forecast period. This market research report provides a comprehensive analysis of the global market, including market size, share, demand, industry development status, with medical device plastics market trends and forecasts for the next few years. The growth of the medical device plastics market is being propelled by a combination of technological, demographic, and regional factors. Global healthcare spending, expanding medical device manufacturing base, and rapid adoption of advanced, diagnostic, and therapeutic technologies are driving consistent demand for high-performance plastic components. The healthcare expenditure in the US reached USD 4.9 trillion in 2023, accounting for 17.6% of GDP, with strong momentum in hospital care, diagnostics, and home healthcare all major consumers of molded plastic parts.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=122410426
Standard plastics segment to account for largest market share in terms of value during the forecast period
The standard plastics segment leads the medical device plastics market, primarily due to its cost-effectiveness, ease of processing, and wide applicability across disposable and noninvasive medical devices. Materials such as polypropylene (PP), polyethylene (PE), and PVC are widely used in products like tubing, syringes, diagnostic housings, and IV components, where high volume and regulatory compliance are critical. The dominance of this segment is further reinforced by the growing demand for single-use and sterile medical devices, driven by infection control measures and cost containment in healthcare settings. Additionally, ongoing advancements in polymer formulation and cleanroom molding technologies have improved the clarity and chemical resistance of standard plastics, making them more suitable for various medical applications.
Injection molding segment to account for the largest market share in terms of value during the forecast period
The injection molding process dominates the medical device plastics market due to its high precision, scalability, and suitability for complex geometries required in modern medical devices. It enables the mass production of consistent, contamination-free components such as diagnostic housings, connectors, syringes, and wearable device casings. Market growth is being fueled by the increasing demand for miniaturized and lightweight medical devices, alongside advancements in micro- and multi-material injection molding that allow integration of multiple functions into a single component. Moreover, the rise in contract manufacturing partnerships and automation in cleanroom environments across North America and other regions has enhanced production efficiency and reduced defects. With its ability to combine cost-effectiveness, precision, and regulatory compliance, injection molding remains the preferred manufacturing process for both OEMs and medical device molders worldwide.
Drug delivery systems segment to account for the largest market share in terms of value during the forecast period
The drug delivery systems segment leads the medical device plastics market globally, supported by rising demand for advanced, patient-friendly, and self-administrable devices. In the Asia Pacific, the market is witnessing strong growth driven by expanding pharmaceutical manufacturing, rapid urbanization, and increasing government support for local medical device production, particularly in China, India, and South Korea. Meanwhile, Europe is seeing momentum from the shift toward sustainable and recyclable materials in drug delivery devices, aligned with the EU’s stringent medical device regulation (MDR) and environmental policies. The combination of aging populations, rising chronic disease prevalence, and technological advancements such as connected drug delivery systems and smart injectors continues to position this segment as the leading application area in the medical device plastics market.
Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=122410426
North America to account for the largest market share in terms of value during the forecast period
North America leads the medical device plastics market, driven by its well-established healthcare infrastructure, strong R&D capabilities, and the presence of major medical device manufacturers and contract molders. The region’s leadership is reinforced by stringent FDA regulations, which encourage the use of biocompatible and high-performance plastics in critical medical applications. Additionally, domestic manufacturing initiatives, such as the “Buy American” policy and new production investments by companies like Abbott, Medtronic, Jabil, and SMC Ltd., are strengthening local supply chains. With strong innovation in wearables, diagnostic devices, and drug delivery systems, alongside the expansion of cleanroom injection molding capacity, North America remains the global hub for precision-molded medical plastic components.
Medical Device Plastics Companies
Prominent companies include Jabil Inc. (US), Phillips Medisize (US), Donatelle Plastics, LLC (US), Spectrum Plastics Group (US), Bemis Manufacturing Company (US), Nolato (Sweden), Trelleborg AB (Sweden), Freudenberg Medical (US), Viant (US), and SMC Ltd. (US).
Jabil Inc. (US)
Jabil Inc. is recognized as one of the world’s foremost providers of engineering, manufacturing, and supply chain solutions, offering comprehensive services that span the entire product lifecycle from innovation and design to fabrication, assembly, and delivery. The company’s integrated approach enables its clients to streamline manufacturing operations, enhance supply chain efficiency, reduce inventory and logistics costs, and accelerate time-to-market. Operating through dedicated business units that serve as single points of contact, Jabil combines advanced electronic design and design-for-manufacturability expertise with highly automated, continuous-flow production systems. These business units are supported by cross-functional teams that leverage Jabil’s extensive global network and technical capabilities to deliver optimized solutions across a wide range of industries. With operations in more than 25 countries and over 100 strategically located sites, Jabil’s network of healthcare sites consists of 35 manufacturing sites in 12 countries and more than 40 million square feet of manufacturing space. It employs a global workforce of approximately 135,000 people. The company’s major production facilities are in China, Malaysia, Mexico, and the US. Jabil’s operation segments are structured into three key business segments: Regulated Industries, Intelligent Infrastructure, and Connected Living and Digital Commerce. The Regulated Industries segment focuses on automotive and transportation, healthcare and packaging, and renewables and energy infrastructure. Under this segment, the company offers medical device plastic products. Intelligent Infrastructure focuses on artificial intelligence (AI), cloud and data center systems, and networking technologies. In contrast, Connected Living and Digital Commerce prioritize digitalization, automation, and robotics, particularly in warehouse automation solutions. With a strong global presence in North America, South America, Europe, and the Middle East & Africa, Jabil leverages its innovation-driven mindset and commitment to operational excellence to support advanced product development and sustainable manufacturing for leading companies around the world.
Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=122410426
Phillips Medisize (US)
Phillips Medisize, a Molex company under Koch Industries, is a global contract development and manufacturing organization (CDMO) specializing in the design, development, and production of drug delivery systems, medical devices, and in vitro diagnostic (IVD) solutions. With over 60 years of innovation and a workforce of more than 6,000 employees, the company operates 30 global facilities across 11 countries, including seven innovation centers strategically located in North America, Europe, and Asia. Phillips-Medisize generates annual revenues exceeding USD 1.6 billion, positioning it among the world’s foremost medical CDMOs. As a privately owned company, Phillips-Medisize benefits from the scale, stability, and long-term investment strategy of Koch Industries, one of the largest privately held corporations globally, with annual revenues surpassing USD 125 billion. This backing enables Phillips-Medisize to focus on sustainable, long-term partnerships rather than short-term profitability, ensuring customers receive consistent quality, flexibility, and collaborative support throughout the product lifecycle. The company’s operations are structured across four primary divisions: Pharmaceutical, MedTech, In Vitro Diagnostics, and Non-Medical. Within these divisions, Phillips-Medisize provides comprehensive services ranging from concept design and prototyping to precision molding, automated assembly, packaging, and full-scale production. Its advanced capabilities in injection molding, micro-molding, metal injection molding (MIM), and electronics integration enable the company to deliver high-performance components and complete systems for complex medical devices.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook.
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/medical-device-plastics-market-122410426.html
Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: Medical Device Plastics Market 2026 Latest Innovations, Trends, Growth Factors and Opportunities by 2030 | Expert Review
